Ursula von der Leyen, president of the European Commission (John Thys, Pool via AP)
Covid-19 roundup: European Commission prepares to sue for AstraZeneca doses — report; NIH adds polyclonal antibody to ACTIV-2 trial
The European Commission wants the vaccine doses that AstraZeneca pledged to the bloc — and it’s willing to launch legal proceedings to get them, according to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.